Table 3

Baseline haemodynamics, cardiac structure, and cardiac function of control subjects and cirrhotic patients

Controls Pre-ascitics Ascitics
n  12  18  21
Heart rate (beats/min)  65 (4)  71 (2)  73 (4)
Mean arterial blood pressure (mm Hg)  92 (4)  90 (2)  87 (2)
Cardiac index (l/min/m2)  2.33 (0.22)  2.19 (0.17)  2.40 (0.20)
Systemic vascular resistance (dyn s/cm5)1962 (166)1866 (163)1648 (203)
Ejection fraction (%)  59.7 (2.1)  64.7 (2.6)3-150   65.9 (2.0)3-150
End diastolic volume (ml) 103 (12)  99 (7)  82 (6)3-150
End systolic volume (ml)  46 (6)  34 (4)  26 (3)3-160 3-151
Isovolumic relaxation time (ms)  78.4 (3.7)  89.9 (2.8)3-150   94.6 (4.0)3-160
Deceleration time (ms) 218 (11) 208 (12) 236 (18)
E/A ratio  1.34 (0.11)  1.20 (0.10)  0.97 (0.05)3-150
Left atrial size (mm)  36.3 (6.2)  42.7 (1.3)3-150   41.6 (0.9)3-150
Interventricular septal thickness (mm)  8.8 (0.3)  10.6 (0.3)3-150   10.7 (0.4)3-150
Left ventricular relative wall thickness  0.38 (0.01)  0.42 (0.01)  0.46 (0.02)3-160
  • 3-150 p<0.05,

  • 3-160 p<0.01 versus controls;

  • 3-151 p<0.05 ascitic versus pre-ascitic cirrhotic patients.